131 related articles for article (PubMed ID: 24393868)
1. [Safety and feasibility of gastrectomy after neoadjuvant chemotherapy for gastric cancer].
Aoyama T; Hayashi T; Fujikawa H; Ogata T; Cho H; Wada H; Kitani Y; Yukawa N; Oshima T; Rino Y; Ozawa Y; Masuda M; Yoshikawa T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1621-2. PubMed ID: 24393868
[TBL] [Abstract][Full Text] [Related]
2. Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer.
Téoule P; Trojan J; Bechstein W; Woeste G
Dig Surg; 2015; 32(4):229-37. PubMed ID: 25966823
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy with combined S-1 plus weekly low-dose cisplatin followed by surgical resection for advanced gastric cancer].
Isobe T; Hashimoto K; Kizaki J; Miyagi M; Aoyagi K; Koufuji K; Shirouzu K
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1331-5. PubMed ID: 24105055
[TBL] [Abstract][Full Text] [Related]
5. [A patient with advanced gastric cancer who responded to neoadjuvant S-1 plus cisplatin chemotherapy].
Tanaka H; Doi K; Ogata K; Inoue K; Sugiyama S; Iwatsuki M; Furuhashi S; Ogawa K; Takamori H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2207-9. PubMed ID: 24394061
[TBL] [Abstract][Full Text] [Related]
6. Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.
Hayashi T; Aoyama T; Tanabe K; Nishikawa K; Ito Y; Ogata T; Cho H; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Yoshikawa T
Ann Surg Oncol; 2014 Sep; 21(9):3015-22. PubMed ID: 24715213
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210).
Iwasaki Y; Sasako M; Yamamoto S; Nakamura K; Sano T; Katai H; Tsujinaka T; Nashimoto A; Fukushima N; Tsuburaya A;
J Surg Oncol; 2013 Jun; 107(7):741-5. PubMed ID: 23400787
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.
Fushida S; Fujimura T; Oyama K; Kinoshita J; Fujita H; Ninomiya I; Ohta T
Hepatogastroenterology; 2010; 57(104):1650-4. PubMed ID: 21443137
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of neoadjuvant chemotherapy with S-1/CDDP (SP) to the patients with large type 3 and type 4 gastric cancer].
Katayanagi S; Nomura T; Sumi T; Suda T; Hoshino S; Ito K; Takagi Y; Tsuchida A; Kawachi S; Shimazu M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2214-6. PubMed ID: 24394063
[TBL] [Abstract][Full Text] [Related]
13. [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy].
Shioiri T; Inoue S; Kusano T; Umekita N; Kitamura M; Warabi M; Kawahara Y
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1327-30. PubMed ID: 16184934
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of patients with advanced gastric cancer undergoing S-1/CDDP combined neoadjuvant chemotherapy].
Kikuchi D; Ishii Y; Saitou M; Yamada M; Takenoshita S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1113-7. PubMed ID: 21772093
[TBL] [Abstract][Full Text] [Related]
15. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
16. Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
Tamura S; Fujitani K; Kimura Y; Tsuji T; Matsuyama J; Iijima S; Imamura H; Inoue K; Kobayashi K; Kurokawa Y; Furukawa H;
Oncology; 2011; 80(5-6):296-300. PubMed ID: 21778769
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized Phase II trial (LANDSCOPE trial).
Yoshikawa T; Fukunaga T; Taguri M; Kunisaki C; Sakuramoto S; Ito S; Morita S; Tsuburaya A
Jpn J Clin Oncol; 2012 Jul; 42(7):654-7. PubMed ID: 22547727
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer.
Zhang J; Chen RX; Zhang J; Cai J; Meng H; Wu GC; Zhang ZT; Wang Y; Wang KL
Chin Med J (Engl); 2012 Jun; 125(12):2144-50. PubMed ID: 22884144
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).
Yoshikawa T; Omura K; Kobayashi O; Nashimoto A; Takabayashi A; Yamada T; Yamaue H; Fujii M; Yamaguchi T; Nakajima T
Eur J Surg Oncol; 2010 Jun; 36(6):546-51. PubMed ID: 20541062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
